The comparably lower rates of CTCs in patients under endocrine treatment showed a decreasing trend from 8.8% to 2.9% for intact CTCs and from 5.9% to 2.9% for apoptotic CTCs [ 19 ]. 4.
← all excerpts
Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of Principle.
1
—
—